暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
PLUR Pluri Inc
- 5.6400
- +0.2700+5.03%
收盘价 05/02 16:00 (美东)
- 5.4900
- -0.1500-2.66%
盘后 16:17 (美东)
2924.35万总市值-1215市盈率TTM
5.9000最高价5.4056最低价4.04万股成交量5.6000今开5.3700昨收22.59万成交额1.29%换手率亏损市盈率(静)518.50万总股本8.560052周最高6.65市净率1767.16万流通值3.448852周最低--股息TTM313.33万流通股38400.0000历史最高--股息率TTM9.21%振幅3.4488历史最低5.5950平均价1股每手
全部分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
周四盘前交易时段，12只医疗保健股走势
在周四的盘前交易中，GainersProcessa Pharma（纳斯达克股票代码：PCSA）股价上涨了31.2％，至2.12美元。该公司的市值为600万美元。Cyclacel 制药（纳斯达克股票代码：CYCC）
快讯 | Pluri Inc：4月15日，收到纳斯达克的来信，称该公司已恢复遵守纳斯达克上市规则5550 (a) (2)
周一盘后交易时段，12只医疗保健股走势
在周一的盘后交易中，GainerSkineta（纳斯达克股票代码：KA）股价上涨了24.3％，至0.67美元。他们已发行股票的市值为730万美元。Moleculin Biotech（纳斯达克股票代码：MBRX）股票
行业最新消息：医疗保健股午后下跌
周一下午晚些时候，医疗保健股走软，纽约证券交易所医疗保健指数和医疗保健精选板块SPDR基金（XLV）各下跌约0.2％。iShares生物技术ETF（IBB）上涨了0。
行业更新：医疗保健
周一下午晚些时候，医疗保健股走软，纽约证券交易所医疗保健指数和医疗保健精选板块SPDR基金（XLV）各下跌0.2％。iShares生物技术ETF（IBB）上涨0.2％。在
Pluri 获得美国免疫细胞扩张专利
Pluri（PLUR）周一表示，它已获得一项新的美国免疫细胞扩张技术专利。新专利解决了异基因细胞疗法中的挑战，包括有限的捐赠者
评论
$Pluri Inc(PLUR.US$
NEWS
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Pluri Inc. launched a novel immunotherapy platform for solid tumor cancer treatment utilizing placental MAIT cells, a unique type of immune cells with great potential. Pluri's proprietary technology overcomes challenges in expanding MAIT cells, offering advantages over conventional T cells. The global cancer immunotherapy market is projected to reach $275.11 ...
NEWS
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Pluri Inc. launched a novel immunotherapy platform for solid tumor cancer treatment utilizing placental MAIT cells, a unique type of immune cells with great potential. Pluri's proprietary technology overcomes challenges in expanding MAIT cells, offering advantages over conventional T cells. The global cancer immunotherapy market is projected to reach $275.11 ...
Update
$Pluri Inc(PLUR.US$ Pluri Inc: on April 15, Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq Listing Rule 5550(a)(2)
News
$Pluri Inc(PLUR.US$ Pluri Introduces Groundbreaking Immune Cell Expansion Technology, Secures New US Patent
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Ex...
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Ex...
2
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅